<p>Interview with Marc Bonaca, MD, author of <a href= "http:/cardiology.jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2016.2110"> Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction</a>, and John Bittl, MD, author of <a href= "http:/cardiology.jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2016.2252"> Extended Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction</a></p>

Interview with Marc Bonaca, MD, author of Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction, and John Bittl, MD, author of Extended Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction

<p>Interview with Marc Bonaca, MD, author of <a href="http:/cardiology.jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2016.2110" rel="noopener noreferrer"> Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction</a>, and John Bittl, MD, author of <a href="http:/cardiology.jamanetwork.com/article.aspx?doi=10.1001/jamacardio.2016.2252" rel="noopener noreferrer"> Extended Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction</a></p>

Antiplatelet Therapy for Long-term Secondary Prevention After AMI

Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide.
JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.

Science

Medicine

Health & Fitness

Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.

Share Antiplatelet Therapy for Long-term Secondary Prevention After AMI

Sign up to save your podcasts

Antiplatelet Therapy for Long-term Secondary Prevention After AMI

Antiplatelet Therapy for Long-term Secondary Prevention After AMI

More shows like JAMA Cardiology Author Interviews

JAMA Editors' Summary

NEJM This Week

JACC This Week

This Week in Cardiology

JAMA Clinical Reviews

JAMA Pediatrics Editors' Summary

Circulation on the Run

Mayo Clinic Talks

JAMA Dermatology Author Interviews

JAMA Internal Medicine Author Interviews

JAMA Neurology Author Interviews

JAMA Oncology Author Interviews

JAMA Ophthalmology Author Interviews

JAMA Otolaryngology–Head & Neck Surgery Author Interviews

JAMA Pediatrics Author Interviews

JAMA Psychiatry Author Interviews

JAMA Medical News

Eagle's Eye View: Your Weekly CV Update From ACC.org

Core IM | Internal Medicine Podcast

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

JAMAevidence Care at the Close of Life

JAMAevidence The Rational Clinical Examination

JAMAevidence Users' Guides to the Medical Literature

ACC CardiaCast

Annals On Call Podcast

JAMA Network Open Conversations

ESC Cardio Talk

Cardionerds: A Cardiology Podcast

Coronavirus (COVID-19) Q&A

JAMAevidence JAMA Guide to Statistics and Methods

JAMA Health Forum Conversations

JAMA Author Interviews